Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 2,492 followers.

RT @FlorianSlimano: Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pum…

15 Dec 2018

Reply Repost Favourite

Increase in #cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with #PPIs: a possible #DDI? https://t.co/V6NcNSL2BW

15 Dec 2018

Reply Repost Favourite

RT @FlorianSlimano: Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pum…

15 Dec 2018

Reply Repost Favourite

Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction? https://t.co/q62P1rBEmT

15 Dec 2018

Reply Repost Favourite